SiliconInvestor
     Advanced Search   [ sign in ]

sponsor
Sponsor

 Biotech / Medical : Isis Pharmaceuticals (ISIP)

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: TinaK who wrote (2173)7/27/1998 12:55:00 AM
From: John ZwienerRead Replies (1) of 4667
 
Tina, I'm only aware of the published phase 2 data in the press release (2302 in chron's disease). What data was talked about in meetings that was not put in a press release? You indicate it is better than Avakine, but with the limited data out so far, I think we can say it is roughly equivalent or a little less (though it may work on different cases of chrons than avakine) (also, the data is limited, so yes, it could end up being proven to be better than avakine).

Is there additional data, interrim data that was discussed somewhere. Fill us in if there was.
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.